This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
This blog post summarizes the critical insights shared during this informative session. Dimitris Agrafiotis to discuss the current state and future directions of drug discovery informatics in large pharmaceutical organizations led by CDD's Founder and CEO, Dr. Barry Bunin.
And we can’t think of any better way to start off our holiday season than by thanking the twelve guest bloggers and subject matter experts who have contributed to our blog in 2024. It’s a very thankful time of year for those of us at Addgene!
The venture firm’s “modest” $450 million fund, a lower total than some of its peers recently raised, reflects lessons learned after Atlas grew too quickly, partner Bruce Booth wrote in a blog post.
When I last wrote about AI on this blog three years ago, I spoke of it being a tool with the potential to transform scientific discovery, but the application I described was primarily theoretical. … The post AI Unleashed: Transforming Drug Discovery from Theory to Practice appeared first on Plenge Gen @rplenge.
In this blog, we’ll break down the mechanism of action of the most common antibiotic resistance genes and which applications are best (or worst) for each antibiotic. Plasmids need antibiotic resistance genes so that you can specifically isolate bacteria containing your constructs of interest.
In 2014, we wrote a blog post on CRISPR’s potential for correcting monogenetic diseases. There can be no doubt that CRISPR/Cas9 technology has been a breakthrough for the genome-editing field and the greater scientific community.
In this blog post, we’ll focus on the preclinical innovations and trends expected to reshape biomarker analysis. These innovations promise to enhance the precision and efficacy of early-stage research, setting a solid foundation for subsequent clinical applications and enabling the development of more personalized medicine.
This blog highlights select research and prevention efforts from the National Institute for Occupational Safety and Health (NIOSH) and NSC in this year’s focus areas of safety engagement; roadway safety; risk reduction; and slips, trips and falls. For each week of the month, the National Safety Council (NSC) identifies a theme to focus on.
In this blog, we’ll be sharing more details about the disease and discussing opportunities for individuals to get involved in Parkinson’s research. Receiving a Parkinson’s diagnosis is a life-altering event that nearly 1 million people in the United States have experienced. Parkinson’s disease symptoms can vary from person to person.
Valentine We recently blogged about a new December 2024 draft guidance about accelerated approval (the December 2024 draft guidance). This blog post focuses on interpreting these new authorities with respect to timely conduct of confirmatory trials. Tobolowsky & Charles G. Raver & James E.
This blog delves into the intricacies of stromal-tumor interactions, with a focus on co-culture systems and tumor microenvironment analysis as essential tools for unraveling resistance mechanisms.
This blog post is part of a series that will explore applications and expansions of the Open Targets informatics ecosystem, particularly the Open Targets Platform and Open Targets Genetics through conversations with our users.
In this blog post, we will show you how to configure ServiceNow knowledge articles as a data source for Microsoft Search using the Microsoft Graph connector. We hope this blog post was helpful and you learned how to configure ServiceNow knowledge articles for Microsoft Graph Connector.
In this blog post, I want to focus on a different quote with the same intent. When Quantity Goes Wrong I wrote another blog post on lessons learned while managing corporate innovation. Pablo Picasso said, “Inspiration exists, but it has to find you working.” Have a hundred ideas and throw away the bad ones. You’ll drown.
In this blog, we’ll outline the key steps and best practices for using Groovy scripts to automate content updates. MoreAEM Insights Don’t miss out on more AEM insights and follow our Adobe blog ! However, manual updates, like rolling out a new template, can become tedious and costly when dealing with thousands of pages.
FDA Law Blog is a conference media partner. Hyman, Phelps & McNamara, P.C.s As such, we can offer our readers a special 10% discount. The discount code is: D10-999-FDA25. You can access the conference brochure and sign up for the event here.
In this blog, we will discuss what a combination product is, why there is a particular advantage for inhaled products, and regulatory factors that apply to CMC activities. What is a combination product?
He also writes on a blog focused on the intersection of biology and AI at owlposting.com. However, for now, we have a promising process for generating some of the most complex enzymes on Earth, which could plausibly extend to new classes of enzymes altogether.
How much of that critique could be translated into an effective regulatory (or deregulatory) agenda in light of constraints on FDA’s authority and other factors will be the subject of another blog posting, but the power of the bully pulpit should not be underestimated.
In our latest blog post, we dive into the best practices for drug patent portfolio management. With billions of dollars on the line, effective patent portfolio management can make all the difference between success and failure. But what does it take to excel in this field?
Learn more about implementing a successful generic drug launch strategy by reading our latest blog post: [link] Have you had success with a recent launch? Share your insights and best practices in the comments below!
BRAIN at 10: A View from the National Institute on Drug Abuse mfleming Wed, 09/25/2024 - 19:31 Nora's Blog October 1, 2024 By Nora Volkow, MD, Director, and Rita Valentino, Ph.D., Director, Division of Neuroscience and Behavior, NIDA This blog was originally posted on the The BRAIN Blog.
As such, we can offer our readers a special 10% discount. The discount code is: D10-999-FDA25. You can access the conference brochure and sign up for the event here.
Stay Tuned for More on AI-Driven Development This blog is part of a larger conversation on how Microsoft Copilot is transforming the workplace. If youre looking to accelerate software development and enhance coding efficiency, now is the time to explore how Copilot can transform your workflow.
We recently hosted an insightful webinar featuring the team from Congruence Therapeutics , who shared how they're using CDD Vault alongside their proprietary systems to manage complex drug discovery data.
The rest of this blog will focus on the Clinical Trials Grants Program. These studies are crucial because understanding the natural course of a disease helps in designing better clinical trials and defining meaningful endpoints for future drug development.
This Blog post will consider the features of the 'perfect' assay description and provide a guide for depositors on the submission of high quality data. More details on these tables will follow in a future Blog post. These would also support ChEMBL's ongoing efforts towards an in vitro assay classification. Q uestions?
1-3 In this blog we examine bacterial metabolism: its scope, its interest to researchers, and how diverse applications, including those linked to metabolic control, measurement of metabolites and bacterial growth, can be determined using microplate readers. 2 in this blog adapted from this reference under license CC-BY 4.0.
In December 2023, FDA established the Genetic Metabolic Diseases Advisory Committee (also called “GeMDAC,” which we blogged about here ) to advise FDA regarding treatments for genetic metabolic diseases (i.e., those reviewed by the CDER Division of Rare Diseases and Medical Genetics).
And stay tuned to our Salesforce blog for all our post-conference insights. Visit #PerficientDreamforce2024 to learn more. Can’t Make it to Dreamforce? Don’t worry! Schedule some time with us and let our experts fill you in.
In this blog, well explore the strengths, features, and considerations of each framework to help you make an informed decision. Best for: Blog posts, marketing pages, documentation. Two of the most prominent frameworks in the React ecosystem today areRemixandNext.js. What is Remix? Caching Strategies Next.js
Stay tuned for more insightful blogs! The next time you write an Apex class that interacts with sensitive fields, remember to check field level security before exposing data! Want to learn more about Salesforce security best practices?
In this blog, we explored how Pulumi can deploy AWS services like EC2, S3, RDS, and Lambda, along with an architecture diagram to illustrate the deployment. Conclusion Pulumi is a powerful Infrastructure-as-Code (IaC) tool that enables developers to provision and manage AWS resources using familiar programming languages like Python.
Part 2 Our first blog covered the ABCs of Artificial Intelligence (AI) and AIs evolution. This post discusses key issues pharma executives must consider to ensure responsible, compliant, and successful AI implementation within their organizations. The stakes for AI adoption in the pharmaceutical industry have never been higher.
This blog explores the process required for manufacturing a highly potent API for an ophthalmic indication, based on a case study involving loteprednol etabonate, a topical corticosteroid used to treat eye inflammations.
To learn more about Perficients Sitecore solutions, visit our partner page , subscribe to Perficients blog , and follow us on LinkedIn. Being awarded the 2024 Sitecore Practice Excellence Award Global Winner , we will continue to implement and deliver enterprise-level sites that maximize this digital experience platform.
This blog post delves into OmniStudio, exploring its capabilities, benefits, and how you can leverage it to elevate your customer journeys. In today’s digital landscape, delivering exceptional customer experiences is paramount. What is Salesforce OmniStudio?
The purpose of this series of blog posts is to dive into these hidden factors that shape estimates. These initial estimates get blended, adjusted for unknown surprises, and finalized – sometimes after fighting it out in a debate, or we might get fancy with an adjusted average from three-point estimating.
Part 1 of this new blog series will focus on what KubeOne is, its features, and its architecture. KubeOne aims to provide a reliable and automated solution for provisioning, managing, and scaling Kubernetes clusters. It focuses on high availability, self-healing, and ease of maintenance across multiple nodes and environments. What is KubeOne?
I could talk about each of these components in detail, but for the purposes of this blog and brevity, let me say that organizations need to decide what data of all the data inside and outside the organization they want to collect. The organization then must collect the data in a Data Lake.
In our latest blog post, we dive into the strategies and challenges of patenting drug combinations. One area that's gaining significant attention is drug combinations pairing two or more active ingredients to create a more effective therapy. But, have you ever wondered what it takes to successfully patent these complex combinations?
For example, my recent blog, Advocate for Digital Accessibility from Your Desk , was greatly influenced by conversations with two colleagues who are experts in digital accessibility.” Nicole: I have learned so much working with the PRISM ERG and connected with many colleagues I would otherwise not have met.
We organize all of the trending information in your field so you don't have to. Join 15,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content